Military Industrial Complex Logo

BioProtection Systems Corporation Contract Details



Defense contract under the Defense Threat Reduction Agency awarded to BioProtection Systems Corporation on 9/3/2015.

Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater.


The contract language is EXACTLY as it appears on the official U.S. DoD website (http://www.defense.gov/contracts/) unless otherwise noted.




Contractor: BioProtection Systems Corporation
Department: Defense Threat Reduction Agency
Awarded: 9/3/2015


BioProtection Systems Corp., Ames, Iowa, is being awarded an $8,168,814 cost-plus-fixed fee contract to advance the rVSV ZEBOV-GP (BPSC1001) candidate Ebola Zaire vaccine towards regulatory approval. This effort will be performed primarily at the contractor location in Ames, Iowa, with additional work being accomplished at various locations including, Manhattan, Kansas, Frederick, Maryland, Cambridge, Massachusetts, Columbus, Ohio, and Washington, District of Columbia. The estimated completion date for the base period of the contract is Sept. 8, 2016. Fiscal 2015 research, development, test and evaluation funds in the amount of $8,168,814 are being obligated at time of award. This contract was a competitive acquisition under a broad agency announcement. The Defense Threat Reduction Agency, Ft. Belvoir, Virginia is the contracting activity (HDTRA1-15-C-0058).


Total Contract Value: $8,168,814


View all contracts that include "BioProtection Systems Corporation" in the MiC database.